logo/base Created with Sketch.

FibroScan® Mini+ 430

The mobile non-invasive solution for liver disease management, ideal for multi-site configuration

Powered by LSM by VCTE and CAP* for liver fibrosis and liver steatosis assessment.

wave

FibroScan® Mini+ 430 is designed for multi-center sharing and remote liver patient management.

Awarded ergonomic design

LSM by VCTE™ is unique, patented and validated for liver fibrosis assessment. It is the standard for non-invasive evaluation of liver stiffness with 2,250 international peer-reviewed publications.1

CAP  is unique patented and validated for liver steatosis assessment2,3 with 330 international peer-reviewed publications.
*CAP is available as an option.

What our users say

quote

Assessment of liver stiffness and fat by non-invasive method is a huge step forward towards better management of NAFLD. It has hugely impacted the way clinicians stratify the patients, chose therapy and monitor response!

Akash Shukla | Professor & Head Department of Gastroenterology Seth GSMC & KEM Hospital Mumbai

chevron chevron

Products in the FibroScan® range are Class IIa medical devices as defined by Directive 93/42/EEC (EC 0459). These devices are designed for use in a medical practice in order to measure liver stiffness and ultrasound attenuation in patients with liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.

 

References are available in our bibliography.